Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Adored Beast Apothecary Ltd. maintains a patent portfolio with 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single active matter is situated within 1 distinct art unit, reflecting the current prosecution footprint. The involvement of a distinct examiner means that the company's current success in this area relies on the interactions with a single official at the patent office. Such a structure allows for a specialized approach to the technical claims being presented.
HOFFMAN, SUSAN COE serves as the busiest examiner for the company, managing the pending office action currently on record. This arrangement suggests that the legal strategy does not need to account for varying examiner behaviors across different departments. With only a single pending office action, the administrative burden is focused, and the outcome of this specific case is critical for the portfolio's growth in the Biotechnology & Pharmaceuticals sector. The applicant must ensure that the arguments presented to the distinct art unit are robust enough to withstand the scrutiny of the assigned examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041476 | NATURAL PRODUCT EXTRACTS AND METHODS OF USE THEREOF | HOFFMAN, SUSAN COE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041476 | NATURAL PRODUCT EXTRACTS AND METHODS OF USE THEREOF | HOFFMAN, SUSAN COE | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18041476 | NATURAL PRODUCT EXTRACTS AND METHODS OF USE THEREOF | HOFFMAN, SUSAN COE | 1655 | §101§103§112 | Final Rejection | — | Pending | Feb 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Adored Beast Apothecary Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Susan Coe Hoffman has the most, with 1 of The Adored Beast Apothecary Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
